My watch list
my.bionity.com  
Login  
NEWS
Current news

Mymetics-Led Consortium Awarded €8.4 Million for Development of Thermo Stable and Cold-Chain Independent Vaccines

Mymetics Corporation  announced that its subsidiary Mymetics BV in the Netherlands is leading a consortium that has been selected to receive project grants with a total value of €8.4 million. A total of €5.3 million is funded as part of Horizon 2020, the European Union research and innovati ... more

Novel regulator inhibits toxic protein aggregates in Huntington's disease

Huntington's disease is a neurodegenerative disorder characterized by huntingtin protein aggregates in a patient's brain, but how these aggregates form is not well understood. In a study published in Genome Research, researchers developed a novel computational strategy to identify interacti ... more

Nanoparticle drug reverses Parkinson's-like symptoms in rats

As baby boomers age, the number of people diagnosed with Parkinson's disease is expected to increase. Patients who develop this disease usually start experiencing symptoms around age 60 or older. Currently, there's no cure, but scientists are reporting a novel approach that reversed Parkins ... more

Santhera's Positive Phase III Trial (DELOS) in Patients with Duchenne Muscular Dystrophy

Santhera Pharmaceuticals announced that the full results of the double-blind placebo-controlled Phase III trial (DELOS) demonstrating efficacy and safety of Raxone®/Catena® (INN: idebenone) in patients with DMD have been published in The Lancet. The results of the DELOS trial demonstrated t ... more

Scientists X-ray anti-inflammatory drug candidates

Using DESY's ultra bright X-ray source PETRA III, scientists have decoded the molecular and three-dimensional structure of two promising drug candidates from the new group of Spiegelmers for the first time. The results provide a deeper understanding of the mode of action of these substances ... more

Bionomics initiates Phase II clinical trial of anxiety treatment

Bionomics Limited announced the initiation of a Phase II clinical study of BNC210, the Company’s drug candidate in development for the treatment of anxiety and depression.  The study will use functional magnetic resonance imaging (fMRI) to assess the effects of BNC210 on brain activity in p ... more

Prostate Cancer Foundation (PCF) Announces Inaugural Stupski Prize in Prostate Cancer Computational Oncology

The Prostate Cancer Foundation (PCF) announced the Stupski Prize in Prostate Cancer Computational Oncology, a first-in-field initiative designed to attract novel ideas to the rapidly changing field of large-scale cancer bioinformatics. These solutions will help clinicians and researchers op ... more

Cristal Therapeutics Announces Appointment of Jeroen Tonnaer as Chief Business Officer

Cristal Therapeutics, a privately-held life sciences company developing novel nanotherapeutics against cancer and other diseases, announced the appointment of Jeroen Tonnaer as new Chief Business Officer responsible for Cristal Therapeutics’ business development, partnering and licensing ac ... more

New method shows promise in treating antidepressant-resistant depression

A new study by University of Florida researchers could help reveal methods to treat depression when traditional medications aren’t working. To uncover solutions to this problem, UF researchers studied two types of rat models, including one that is particularly sensitive to stress and highly ... more

Antibiotic Armageddon in UK and Europe by 2025

The European Society of Clinical Microbiology and Infectious Disease (ESCMID) – an organization that explores risk assessment, knowledge sharing and best practices in the fight against infectious disease – has warned that Britain and Europe collectively could face more than a million deaths ... more

All news

DNA blood test detects lung cancer mutations

Cancer DNA circulating in the bloodstream of lung cancer patients can provide doctors with vital mutation information that can help optimise treatment when tumour tissue is not available, an international group of researchers has reported at the European Lung Cancer Conference (ELCC) in Gen ... more

Sartorius Stedim Biotech acquires UK-based CRO, BioOutsource

Sartorius Stedim Biotech (SSB) acquired the Scottish company BioOutsource Ltd. The privately owned company based in Glasgow, UK, has been operating in the biotechnology market since 2007, and in the last twelve months earned revenue of around 9 million euros with approx. 85 employees. The c ... more

Belgian Start-up UgenTec Receives Funding from European Investors

UgenTec, a start-up company based in Belgium that develops laboratory software for automating PCR based DNA analysis, announced that it has received more than €1m in venture capital funding from a group of Belgian investors and an additional €250,000 in research funds from the IWT, a govern ... more

Mummified bodies reveal how tuberculosis ravaged the heart of 18th century Europe

Bodies found in a 200 year-old Hungarian crypt have revealed the secrets of how tuberculosis (TB) took hold in 18th century Europe, according to a research team led by the University of Warwick. A new study published in Nature Communications details how samples taken from naturally mummifie ... more

Trapping and watching motile cells

Optical imaging of highly motile cells or cells in suspension, such as bacterial systems, yeast cells, and immune cells, is a challenging task, in many cases it is just not possible. The human immunodeficiency virus (HIV), for example, can spread very efficiently from an infected T cell to ... more

Rapid and efficient DNA chip technology for testing 14 major types of food borne pathogens

Toshiba Ltd and Kawasaki City Institute for Public Health collaborate in the development of a rapid and efficient DNA chip technology for testing 14 major types of food borne pathogens for applications in hygiene management in food manufacture, pharmaceuticals, and cosmetics. The researcher ... more

MDxHealth's ConfirmMDx Genes Detect Clinically Significant Prostate Cancer

MDxHealth SA announced that data demonstrating the prognostic value of its ConfirmMDx® for Prostate Cancer genes and technology was presented at the ASCO Genitourinary Cancers Symposium 2015.  The data support the ability to predict the presence of clinically significant cancer in biopsy-ne ... more

Technology Partnership between Berthold Technologies & Biametrics

Berthold Technologies has recently established a co-operation with its new technology partner Biametrics GmbH. A spin-off of Tübingen University, Biametrics develops novel solutions for label-free analysis of bio-interactions. The 1λ-Reflectometric Interference Detection (1λ-RIDe) is the mi ... more

Huntingdon Life Sciences and Harlan Laboratories to operate under new brand and name

Huntingdon Life Sciences (HLS) and Harlan Laboratories have announced that the two companies will be rebranded to reflect the new integrated management structure that has been put in place and the broader product and service offerings of the combined organizations. One of the world’s leadin ... more

Healthcare is up for a Revolution with the Rise of Personal Genomic Tests

As the era of personalized medicine dawns on healthcare, the need to understand an individual’s genetic information through genomic testing has risen. This emerging branch of medicine has given birth to multiple companies that provide genetic tests to help end users understand their genetic ... more

All news on bioanalytics

Positive Clinical Study Results for Cellmid's Hair Growth Product Using Novel FGF5 Inhibitor

Cellmid Limited has received strong positive results in all measured areas of its independently conducted, randomized, blinded and placebo controlled human clinical study of the évolis ONE formulation. The 32 patient study was conducted with Cellmid’s novel and proprietary FGF5 inhibitor fo ... more

Sartorius Starts Off Fiscal 2015 with a Strong First Quarter

Sartorius started off fiscal 2015 with substantial double-digit gains in order intake, sales revenue and earnings. Group order intake rose 13.1%, excluding currency effects; this reported figure surged 22.7%. Sales climbed 17.2% in constant currencies; the reported figure, 27.0%. Operating ... more

Fruit fly studies shed light on adaptability

An international team of researchers at German Center for Neurodegenerative Diseases (DZNE) and Tokyo Institute of Technology (Tokyo Tech) have revealed in a collaborative study that neurons change on the molecular level when they are exposed to prolonged light. The researchers could identi ... more

Clyde Biosciences secures new investment

Clyde Biosciences Ltd. has announced a £2 million ‘Series A’ investment led by Epidarex Capital, a leading international early-stage life science venture capital fund.  Scottish Enterprise’s investment arm, the Scottish Investment Bank, also participated in the round along with Glasgow Univ ... more

A new tool for understanding ALS: Patients' brain cells

Researchers at Johns Hopkins Medicine have transformed skin cells from patients with Lou Gehrig’s disease, or amyotrophic lateral sclerosis (ALS), into brain cells affected by the progressive, fatal disease and deposited those human-made cells into the first public ALS cell library, enablin ... more

ThromboGenics and VIB launch New Oncology Company

ThromboGenics NV announced the foundation of Oncurious NV, a new oncology company that will develop TB-403 for the treatment of pediatric brain tumors. VIB will become a shareholder alongside ThromboGenics in this new oncology venture. ThromboGenics will be the majority shareholder. TB-403 ... more

Merck Appoints Udit Batra to Head Combined Life Science Business

Merck announced that Udit Batra, currently CEO and President of Merck Millipore, has been appointed to lead the combined life science business of Merck Millipore and Sigma-Aldrich once the acquisition of Sigma-Aldrich has been successfully completed. The planned $ 17 billion transaction rem ... more

CryoLife Announces Retirement of Founder and Executive Chairman Steven G. Anderson

CryoLife, Inc. announced that Steven G. Anderson, 76, Executive Chairman of the Board of Directors, has decided to retire effective immediately.  As a result of his retirement, he will step down from all positions with the company and its subsidiaries, including as a member of the Board of ... more

Scientists a step closer to developing renewable propane

Researchers at The University of Manchester have made a significant breakthrough in the development of synthetic pathways that will enable renewable biosynthesis of the gas propane. This research is part of a programme of work aimed at developing the next generation of biofuels.This study p ... more

Omnivorous bacteria can process plastic into food and clean oil-contaminated soils

Back in 1986 scientists from Tomsk State University (TSU) were working on the problems involved in cleaning up oil spills. This research lead to the discovery of oil-eating bacteria. Vladimir Kaluzhin, a senior research associate with the Research Institute for Biology and Biophysics at Tom ... more

All news on biotechnology

Detecting lung cancer at an early stage

A new diagnostic method, namely spectral histopathology, facilitates marker-free detection of individual subtypes of lung cancers. It was developed by researchers at the PURE consortium at Ruhr-Universität Bochum (RUB). They have successfully applied it in collaboration with clinicians at t ... more

DNA blood test detects lung cancer mutations

Cancer DNA circulating in the bloodstream of lung cancer patients can provide doctors with vital mutation information that can help optimise treatment when tumour tissue is not available, an international group of researchers has reported at the European Lung Cancer Conference (ELCC) in Gen ... more

Aseptika Granted United States Patent for Biomarkers for Respiratory Infection Onset

Aseptika Limited announced that it has been granted a patent in the United States (US) protecting its invention for a test for respiratory infections, designed to be used by patients at home and by clinicians at the bedside of patients in hospitals. This will open up opportunities for the C ... more

Roche strengthens oncology translational research pipeline by acquiring CAPP Medical

Roche announced it has acquired CAPP Medical, a genomics research company founded by Stanford University oncologists and industry veterans, to advance the development of technology for cancer screening and monitoring through the detection of circulating tumor DNA (ctDNA) in blood.  CAPP Med ... more

Bio-marker set forms the basis for new blood test to detect colorectal cancer

Colorectal cancer is the third most common form of cancer globally and the second most common cause of cancer deaths. The chance of a cure is high if the cancer is detected early enough, but early detection is not a given. Researchers from VIB and KU Leuven - together with various European ... more

Philips enters into collaboration with Janssen to develop new handheld blood test

Royal Philips announced that it has entered into a multi-year development agreement with Janssen Pharmaceutica N.V.. The collaboration aims to develop a new handheld blood test to provide doctors with a novel tool to improve the care of patients with neuropsychiatric disorders.The collabora ... more

analytica Vietnam 2015 more international than ever

This year's analytica Vietnam will have approximately 100 exhibitors from 15 countries, making it more international than ever. As part of the extensive program of related events, feature several international experts will pass on scientific background information about research and trends ... more

MDxHealth's ConfirmMDx Genes Detect Clinically Significant Prostate Cancer

MDxHealth SA announced that data demonstrating the prognostic value of its ConfirmMDx® for Prostate Cancer genes and technology was presented at the ASCO Genitourinary Cancers Symposium 2015.  The data support the ability to predict the presence of clinically significant cancer in biopsy-ne ... more

SkylineDx Appoints Oncologist as Acting as Chief Medical Officer

SkylineDx announced the appointment of Saad Usmani, MD, FACP, as their acting Chief Medical Officer.  Dr. Usmani is currently the Director of Clinical Research (Hematologic Malignancies) and Director of Plasma Cell Disorders at Carolinas HealthCare System’s Levine Cancer Institute in Charlo ... more

New screening tool could speed development of ovarian cancer drugs

University of Chicago Medicine researchers have built a model system that uses multiple cell types from patients to rapidly test compounds that could block the early steps in ovarian cancer metastasis. Their three-dimensional cell-culture system, adapted for high-throughput screening, has e ... more

All news on diagnostics

Sartorius Starts Off Fiscal 2015 with a Strong First Quarter

Sartorius started off fiscal 2015 with substantial double-digit gains in order intake, sales revenue and earnings. Group order intake rose 13.1%, excluding currency effects; this reported figure surged 22.7%. Sales climbed 17.2% in constant currencies; the reported figure, 27.0%. Operating ... more

Genevac Consolidate Evaporator & Freeze Dryer Operations In Germany

Genevac has announced, as of 1st April 2015, that LMS Consult GmbH (LMS) has been appointed as the exclusive German distributor for its market leading evaporator systems plus the freeze dryer range of its parent company - SP Scientific.For over 30 years - LMS Consulthave successfully sold a ... more

Ximbio Expands Team

Ximbio announced the expansion of its team, with two new appointments. Dr Hugh Spotswood has joined as Senior Business Manager, and Emily Haggerty as a Scientific Portfolio Associate. Hugh’s role as part of Ximbio is to head up the business development function to maximise the revenue creat ... more

INTEGRA Biosciences Opens German Subsidiary

Following on from the successful launch of subsidiaries in France, the UK and the USA - INTEGRA Biosciences has announced the opening in January 2015 of a new organisation based in Konstanz, Germany.Leveraging an existing knowledgeable local sales and service team – INTEGRA Biosciences Deut ... more

TÜV SÜD explains process maturity according to the new ISO 9001

The final version of the revised standard for quality management systems is scheduled for release by the International Organisation for Standardisation (ISO) in autumn 2015. Many organisations have already started to address the expected changes, which are aimed at strengthening the benefit ... more

analytica Vietnam 2015 more international than ever

This year's analytica Vietnam will have approximately 100 exhibitors from 15 countries, making it more international than ever. As part of the extensive program of related events, feature several international experts will pass on scientific background information about research and trends ... more

Sartorius Reviews Fiscal 2014 Results

Sartorius closed fiscal 2014 with significant gains in sales revenue and earnings. At the annual press conference in Goettingen, Germany, CEO Dr. Joachim Kreuzburg stated that the Group had even slightly exceeded its financial targets and reached important milestones: "Our largest division, ... more

Sartorius: Successful Business Year 2014

Sartorius successfully closed fiscal 2014 according to its preliminary figures, and even slightly exceeded its sales revenue and earnings targets. In addition, the Group is set to further sharpen its strategic profile based on the sale of its smallest division, Industrial Technologies, whic ... more

Seward appoints Dan Crothers as Managing Director

Seward Ltd. announced the appointment of Dan Crothers as Managing Director to direct strategy and implement a series of new developments within the Company. Dan, who has worked with Seward since 2008, assumes the new role after success in previous positions, including managing Seward’s Sing ... more

Merck Obtains US Antitrust Clearance for Acquisition of Sigma-Aldrich

Merck announced that it has obtained antitrust clearance from the United States Federal Trade Commission (FTC) for its planned acquisition of US-based life science company Sigma-Aldrich. The waiting period under the Hart-Scott-Rodino Antitrust Improvements Act (HSR Act) in connection with i ... more

All news on lab technology

Mymetics-Led Consortium Awarded €8.4 Million for Development of Thermo Stable and Cold-Chain Independent Vaccines

Mymetics Corporation  announced that its subsidiary Mymetics BV in the Netherlands is leading a consortium that has been selected to receive project grants with a total value of €8.4 million. A total of €5.3 million is funded as part of Horizon 2020, the European Union research and innovati ... more

Novel regulator inhibits toxic protein aggregates in Huntington's disease

Huntington's disease is a neurodegenerative disorder characterized by huntingtin protein aggregates in a patient's brain, but how these aggregates form is not well understood. In a study published in Genome Research, researchers developed a novel computational strategy to identify interacti ... more

Nanoparticle drug reverses Parkinson's-like symptoms in rats

As baby boomers age, the number of people diagnosed with Parkinson's disease is expected to increase. Patients who develop this disease usually start experiencing symptoms around age 60 or older. Currently, there's no cure, but scientists are reporting a novel approach that reversed Parkins ... more

Santhera's Positive Phase III Trial (DELOS) in Patients with Duchenne Muscular Dystrophy

Santhera Pharmaceuticals announced that the full results of the double-blind placebo-controlled Phase III trial (DELOS) demonstrating efficacy and safety of Raxone®/Catena® (INN: idebenone) in patients with DMD have been published in The Lancet. The results of the DELOS trial demonstrated t ... more

Bionomics initiates Phase II clinical trial of anxiety treatment

Bionomics Limited announced the initiation of a Phase II clinical study of BNC210, the Company’s drug candidate in development for the treatment of anxiety and depression.  The study will use functional magnetic resonance imaging (fMRI) to assess the effects of BNC210 on brain activity in p ... more

Cristal Therapeutics Announces Appointment of Jeroen Tonnaer as Chief Business Officer

Cristal Therapeutics, a privately-held life sciences company developing novel nanotherapeutics against cancer and other diseases, announced the appointment of Jeroen Tonnaer as new Chief Business Officer responsible for Cristal Therapeutics’ business development, partnering and licensing ac ... more

New method shows promise in treating antidepressant-resistant depression

A new study by University of Florida researchers could help reveal methods to treat depression when traditional medications aren’t working. To uncover solutions to this problem, UF researchers studied two types of rat models, including one that is particularly sensitive to stress and highly ... more

Antibiotic Armageddon in UK and Europe by 2025

The European Society of Clinical Microbiology and Infectious Disease (ESCMID) – an organization that explores risk assessment, knowledge sharing and best practices in the fight against infectious disease – has warned that Britain and Europe collectively could face more than a million deaths ... more

Evidence grows that melanoma drugs benefit some lung cancer patients

A subset of lung cancer patients can derive important clinical benefits from drugs that are more commonly used to treat melanoma, the authors of a new academic clinical trial in Europe have reported at the European Lung Cancer Conference (ELCC) in Geneva, Switzerland.Dr. Oliver Gautschi, a ... more

HER-Vaxx Re-Formulation Shows Dramatic Ten-Fold Increase in Antibodies and Early Onset of Response

Imugene Limited, a clinical stage immuno-oncology company developing HER-2 positive gastric and breast cancer immunotherapies, announces that Imugene’s lead candidate HER-Vaxx has demonstrated a powerful increase in the production of cancer fighting antibodies in preclinical animal model te ... more

All news on pharma

Nanoparticle drug reverses Parkinson's-like symptoms in rats

As baby boomers age, the number of people diagnosed with Parkinson's disease is expected to increase. Patients who develop this disease usually start experiencing symptoms around age 60 or older. Currently, there's no cure, but scientists are reporting a novel approach that reversed Parkins ... more

Prostate Cancer Foundation (PCF) Announces Inaugural Stupski Prize in Prostate Cancer Computational Oncology

The Prostate Cancer Foundation (PCF) announced the Stupski Prize in Prostate Cancer Computational Oncology, a first-in-field initiative designed to attract novel ideas to the rapidly changing field of large-scale cancer bioinformatics. These solutions will help clinicians and researchers op ... more

Evidence grows that melanoma drugs benefit some lung cancer patients

A subset of lung cancer patients can derive important clinical benefits from drugs that are more commonly used to treat melanoma, the authors of a new academic clinical trial in Europe have reported at the European Lung Cancer Conference (ELCC) in Geneva, Switzerland.Dr. Oliver Gautschi, a ... more

Tango could benefit Parkinson's disease patients

Dancing the Argentine tango could have potential benefits for people at certain stages in the development of Parkinson’s disease (PD), according to findings in a new study by researchers at the Montreal Neurological Institute and Hospital -The Neuro, McGill University and the Research Insti ... more

Smokers underestimate risks of a few cigarettes

Many people still dangerously underestimate the health risks associated with smoking even a few cigarettes a day, despite decades of public health campaigning, French researchers have reported at the European Lung Cancer Conference (ELCC) in Geneva, Switzerland. The results demonstrate powe ... more

A new tool for understanding ALS: Patients' brain cells

Researchers at Johns Hopkins Medicine have transformed skin cells from patients with Lou Gehrig’s disease, or amyotrophic lateral sclerosis (ALS), into brain cells affected by the progressive, fatal disease and deposited those human-made cells into the first public ALS cell library, enablin ... more

ThromboGenics and VIB launch New Oncology Company

ThromboGenics NV announced the foundation of Oncurious NV, a new oncology company that will develop TB-403 for the treatment of pediatric brain tumors. VIB will become a shareholder alongside ThromboGenics in this new oncology venture. ThromboGenics will be the majority shareholder. TB-403 ... more

How can a microwave save a frostbitten rabbit?

Cases of frostbite account for about 10% of all trauma cases seen in the northern regions of Russia. Treatment can last for two or more months, and almost 90% of these injuries result in disability. However, Tomsk University scientists believe that in many cases the treatment process can be ... more

Brain training instead of medication to counter insomnia

The ability to finally enjoy a good night's sleep is something that can be learned. An Austrian Science Fund FWF project has investigated how this can best be learned and who responds best to such "brain training". Dark circles around the eyes, tired limbs, absent-mindedness – most people ... more

Enzyme in cosmetic products can act as allergen via the skin

Papain is found naturally in papaya and is often referred to as a "plant-based pepsin" in reference to the digestive enzyme pepsin that is present in the stomach. Erika Jensen-Jarolim, Head of the Department of Comparative Medicine at the Messerli Research Institute, and her team researched ... more

All news on healthcare
News by department
News according to country
Companies in the news
News archive
Newsletters

bionity.com Newsletter

The bionity.com newsletter keeps you informed about the current events in the fields of biotechnology, life sciences and medicine with news, products, company profiles and technical information.
Current edition

Your browser is not current. Microsoft Internet Explorer 6.0 does not support some functions on Chemie.DE